<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>CATY - CATY Q3 2025 Share Repurchase Analysis | Evidence Repository</title>
    <link rel="stylesheet" href="../../styles/caty-equity-research.css">
</head>
<body>
    <a class="skip-link" href="#main-content">Skip to main content</a>

    <button class="theme-toggle" type="button" onclick="toggleTheme()" aria-label="Toggle dark mode" role="switch" aria-checked="false">
        <span id="theme-icon" aria-hidden="true">üåô</span>
        <span id="theme-text">Dark Mode</span>
    </button>

    <header>
        <div class="header-content">
            <h1 class="page-title">Cathay General Bancorp (NASDAQ: CATY)</h1>
            <p class="page-subtitle">CATY Q3 2025 Share Repurchase Analysis</p>
            <p class="page-meta">Author: Nirvan Chitnis | Date: October 2025 | Purpose: Evidence documentation</p>
        </div>
    </header>

    <main class="container" id="main-content" tabindex="-1">
        <nav aria-label="Breadcrumb" class="breadcrumb">
            <a href="../../index.html">‚Üê Main Report</a>
            <span aria-hidden="true"> / </span>
            <span aria-current="page">Evidence: CATY Q3 2025 Share Repurchase Analysis</span>
        </nav>

        <p>Prepared October 22, 2025 to support the capital-actions module and CFA review comments.</p>

<h3>1. Transaction Detail</h3>

<ul>
<li>Shares repurchased: <strong>1,070,000</strong> at an average price of <strong>$46.81</strong> (total <strong>$50.1M</strong>).  </li>
</ul>
<p>  Source: Q3 2025 press release (Form 8-K Exhibit 99.1), management commentary paragraph 3 (<code>evidence/raw/CATY_2025Q3_8K/ex_873308.htm</code>, line ~247).</p>

<h3>2. EPS Uplift (Quarterly Run-Rate)</h3>

<table class="data-table">
<thead>
<tr>
<th>Metric</th>
<th>Q3 2025</th>
<th>Q2 2025</th>
<th>Evidence</th>
</tr>
</thead>
<tbody>
<tr>
<td>Diluted average shares</td>
<td>68,990,648</td>
<td>70,188,902</td>
<td>Form 8-K Exhibit 99.1 share count table (<code>ex_873308.htm</code>, lines ~4720)</td>
</tr>
<tr>
<td>Net income (USD M)</td>
<td>77.651</td>
<td>‚Äî</td>
<td>Form 8-K Exhibit 99.1 financial highlights (<code>ex_873308.htm</code>, line ~1745)</td>
</tr>
<tr>
<td>EPS (actual)</td>
<td>1.13</td>
<td>‚Äî</td>
<td>Reported</td>
</tr>
<tr>
<td>EPS (pro forma, Q2 share base)</td>
<td>77.651 √∑ 70.188902 = <strong>1.11</strong></td>
<td>‚Äî</td>
<td>Calculated</td>
</tr>
</tbody>
</table>

<p><strong>Accretion:</strong> ~<strong>$0.02</strong> per share (1.8¬¢) quarter over quarter attributable to the lower share count.</p>

<h3>3. Tangible Book Value Impact</h3>

<ul>
<li>Tangible book value per share (TBVPS) Q3 2025: <strong>$36.96</strong>  </li>
<li>TBVPS Q2 2025: <strong>$36.16</strong>  </li>
</ul>
<p>  (Form 8-K Exhibit 99.1, non-GAAP reconciliation, <code>ex_873308.htm</code>, lines ~6280).</p>

<p>Without deploying the $50.1M, the pro-forma TBVPS would have been <strong>$37.12</strong>, implying <strong>16 bps</strong> of dilution from buying stock at ~<strong>1.29√ó</strong> TBV.</p>

<h3>4. CET1 Headroom</h3>

<ul>
<li>CET1 ratio September 30, 2025: <strong>13.15%</strong> (vs. 13.35% at June 30).  </li>
</ul>
<p>  Source: Form 8-K Exhibit 99.1 capital ratios paragraph (<code>ex_873308.htm</code>, line ~1661).</p>
<ul>
<li>Tangible/common equity (proxy for CET1): <strong>$2,523.9M</strong> (<code>ex_873308.htm</code>, non-GAAP table, line ~6068).</li>
</ul>

<p>Derived risk-weighted assets:</p>

<pre class="code-block"><code>RWA = CET1 $ / CET1% = 2,523.9 / 0.1315 ‚âà $19,193M</code></pre>

<p>Headroom before breaching management‚Äôs 12.0% guardrail:</p>

<pre class="code-block"><code>ŒîCET1 (bps) = 13.15% ‚àí 12.00% = 1.15%
Capital capacity = 0.0115 √ó 19,193 ‚âà $221M</code></pre>

<p>That capacity covers roughly <strong>4√ó</strong> the Q3 deployment.</p>

<h3>5. Authorization Status</h3>

<ul>
<li>Board authorization: <strong>$150M</strong> (July 15, 2024).  </li>
<li>Cumulative spent through Q3 2025: <strong>$90.1M</strong> ‚Üí <strong>$59.9M</strong> remaining.  </li>
</ul>
<p>  Source: <code>data/caty10_capital_actions.json</code> (aggregated from treasury stock footnotes; next update scheduled once the Q3 10-Q posts).</p>

<h3>6. Summary</h3>

<ul>
<li>Buyback lifted quarterly EPS by ~1.8¬¢ and ROTE by ~9 bps through a smaller equity base.</li>
<li>Trade-off: 16 bps of TBV dilution and 20 bps CET1 consumption.</li>
<li>With ~$221M of CET1 headroom to a 12% target and $59.9M left on the authorization, management can continue repurchases but should avoid prices materially above TBV unless incremental ROE is demonstrably accretive.</li>
</ul>


    </main>

    <footer class="evidence-footer">
        <p class="footer-text">Evidence documentation for CFA IRC equity research challenge</p>
        <p class="footer-meta">Author: Nirvan Chitnis | Generated: 2025-10-23 01:13 | Source: CATY_Q3_2025_buyback_analysis.md</p>
    </footer>

    <script src="../../scripts/theme.js"></script>
</body>
</html>
